{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:58:13Z","timestamp":1788209893469,"version":"build-2803163510"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"DOI":"10.1093\/ndt\/gfad230","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T07:26:11Z","timestamp":1698305171000},"page":"727-730","source":"Crossref","is-referenced-by-count":11,"title":["EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association\u2013Immunonephrology Working Group (ERA-IWG) perspective"],"prefix":"10.1093","volume":"39","author":[{"given":"Eleni","family":"Frangou","sequence":"first","affiliation":[{"name":"Department of Nephrology, Limassol General Hospital, Limassol, Cyprus; University of Nicosia Medical School , Nicosia , Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9752-9941","authenticated-orcid":false,"given":"Annette","family":"Bruchfeld","sequence":"additional","affiliation":[{"name":"Department of Health, Medicine and Caring Sciences, Link\u00f6ping University , Link\u00f6ping , Sweden"},{"name":"Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet , Stockholm , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema M","family":"Fernandez-Juarez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Unversitatio La Paz, Madrid, Spain , Spain"},{"name":"; Instituto de Investigacion la Paz, IDIPaZ , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[{"name":"Division of Nephrology, RWTH Aachen University Hospital , Aachen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Goumenos","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Renal Transplantation, Patras University Hospital , Patras , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-4133","authenticated-orcid":false,"given":"Sarah M","family":"Moran","sequence":"additional","affiliation":[{"name":"Cork University Hospital, University College Cork , Cork , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Steiger","sequence":"additional","affiliation":[{"name":"Renal Division, Department of Medicine IV, Ludwig-Maximilians-University Hospital Munich, Ludwig-Maximilians-University Munich , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2291-1692","authenticated-orcid":false,"given":"Kate I","family":"Stevens","sequence":"additional","affiliation":[{"name":"Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital , Glasgow , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kultigin","family":"Turkmen","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Necmettin Erbakan University , Konya , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck , Innsbruck , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"key":"2024042523511704400_bib1","first-page":"ard\u20132023\u2013224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","author":"Fanouriakis","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2024042523511704400_bib2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N Engl J Med"},{"key":"2024042523511704400_bib3","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet North Am Ed"},{"key":"2024042523511704400_bib4","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1177\/0961203319887799","article-title":"Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus","volume":"28","author":"Kandane-Rathnayake","year":"2019","journal-title":"Lupus"},{"key":"2024042523511704400_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13075-016-1202-z","article-title":"Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV","volume":"19","author":"Hanaoka","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2024042523511704400_bib6","doi-asserted-by":"crossref","first-page":"e000169","DOI":"10.1136\/lupus-2016-000169","article-title":"TAC-TIC use of tacrolimus-based regimens in lupus nephritis","volume":"3","author":"Kraaij","year":"2016","journal-title":"Lupus Sci Med"},{"key":"2024042523511704400_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/M14-1030","article-title":"Multitarget therapy for induction treatment of lupus nephritis: a randomized trial","volume":"162","author":"Liu","year":"2015","journal-title":"Ann Intern Med"},{"key":"2024042523511704400_bib8","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/cells12202440","article-title":"Voclosporin: unique chemistry, pharmacology and toxicity profile, and possible options for implementation into the management of lupus nephritis","volume":"12","author":"Kale","year":"2023","journal-title":"Cells"},{"key":"2024042523511704400_bib9","article-title":"Safety and efficacy of long-term voclosporin treatment for lupus nephritis in the phase 3 AURORA 2 clinical trial","author":"Saxena","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2024042523511704400_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2008.102533","article-title":"The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2024042523511704400_bib11","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/rheumatology\/keu148","article-title":"Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus","volume":"53","author":"Ruiz-Arruza","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2024042523511704400_bib12","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2021-220577","article-title":"Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis","volume":"80","author":"Ocon","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2024042523511704400_bib13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2024042523511704400_bib14","article-title":"Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis","author":"Caravaca-Font\u00e1n","year":"2023","journal-title":"Nephrol Dial Transplant"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfad230\/52941819\/gfad230.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/39\/5\/727\/57332492\/gfad230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/39\/5\/727\/57332492\/gfad230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T23:51:59Z","timestamp":1714089119000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/39\/5\/727\/7330214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10,25]]},"published-print":{"date-parts":[[2024,4,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfad230","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2023,10,25]]}}}